Recombinant human parathyroid hormone

From WikiMD's WELLNESSPEDIA

Recombinant Human Parathyroid Hormone (rhPTH) is a synthetic form of the parathyroid hormone (PTH), a protein that is naturally produced by the parathyroid glands. It is used in the treatment of various medical conditions, including osteoporosis and hypoparathyroidism.

Overview[edit]

The parathyroid hormone is a critical regulator of calcium homeostasis in the human body. It acts on the bones, kidneys, and intestine to increase the level of calcium in the blood. Recombinant human parathyroid hormone is a synthetic version of this hormone, produced through recombinant DNA technology.

Medical Uses[edit]

Recombinant human parathyroid hormone is used in the treatment of osteoporosis, a condition characterized by weak and brittle bones. It works by stimulating the formation of new bone, thereby increasing bone density and reducing the risk of fractures.

In addition, rhPTH is used in the treatment of hypoparathyroidism, a condition in which the body produces insufficient amounts of the parathyroid hormone. In this case, rhPTH serves as a replacement for the natural hormone, helping to regulate calcium levels in the body.

Production[edit]

Recombinant human parathyroid hormone is produced using recombinant DNA technology. This involves inserting a gene that codes for the parathyroid hormone into a suitable host organism, such as a bacterium or yeast. The host organism then produces the hormone, which can be harvested and purified for medical use.

Side Effects[edit]

Like all medications, recombinant human parathyroid hormone can cause side effects. These may include nausea, headache, and dizziness. In rare cases, it can cause high levels of calcium in the blood, a condition known as hypercalcemia.

See Also[edit]

Stub icon

This endocrinology article is a stub. You can help WikiMD by expanding the page.

This article is a stub related to pharmacology. You can help WikiMD by expanding it!



This Biotechnology article is a stub. You can help WikiMD by expanding the page.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Recombinant_human_parathyroid_hormone&oldid=6616549"